发明名称 |
Use of neuregulin-4 for treatment of inflammatory bowel disease and necrotizing enterocolitis |
摘要 |
The invention provides methods, pharmaceutical compositions and kits for treating, inhibiting and/or reducing the severity of inflammatory bowel disease and necrotizing enterocolitis in a subject in need thereof by administering an effective amount of a composition comprising an activator of ErbB4. |
申请公布号 |
US9352023(B2) |
申请公布日期 |
2016.05.31 |
申请号 |
US201214236831 |
申请日期 |
2012.08.15 |
申请人 |
Children's Hospital Los Angeles |
发明人 |
Frey Mark R. |
分类号 |
A61K38/16;A61K38/18 |
主分类号 |
A61K38/16 |
代理机构 |
Nixon Peabody LLP |
代理人 |
Vakharia-Rao Hema;Nixon Peabody LLP |
主权项 |
1. A method for treating inflammatory bowel disease in a subject in need thereof comprising:
a. providing Neuregulin-4; and b. administering a therapeutically effective amount of Neuregulin-4 to the subject so as to treat inflammatory bowel disease. |
地址 |
Los Angeles CA US |